164 related articles for article (PubMed ID: 35873630)
1. Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.
Hassanein T; Tai D; Liu C; Box TD; Tong MJ; Rossaro L; Pozza R; Glenn JS; Cheung R; Hemaidan A; He Y; Behling C; Hu X; Makhlouf H; Fan H; Ren Y; Khim Chng EL; Liu P; Vierling JM
Evid Based Complement Alternat Med; 2022; 2022():4494099. PubMed ID: 35873630
[TBL] [Abstract][Full Text] [Related]
2. Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial.
Chen Y; Zhao Z; Fan H; Li Z; He Y; Liu C
Contemp Clin Trials Commun; 2020 Sep; 19():100601. PubMed ID: 32642592
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial.
Zhao ZM; Zhu CW; Huang JQ; Li XD; Zhang YX; Liang J; Zhang W; Zhang Y; Jiang XG; Zong YL; Zhang KJ; Sun KW; Zhang B; Lv YH; Xing HC; Xie Q; Liu P; Liu CH
J Ethnopharmacol; 2022 Nov; 298():115599. PubMed ID: 35932973
[TBL] [Abstract][Full Text] [Related]
4. Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis.
Zhou X; Fu Y; Chen J; Liu P
J Ethnopharmacol; 2024 Jun; 327():118018. PubMed ID: 38453100
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir: A Multicenter Retrospective Cohort Study.
Fan H; Lei S; Zhao Z; Huang Y; Wang H; Liu X; Li X; Xu M; Zhang W; Sun K; Xing H; Mei Y; Huang J; Zhu C; Zhang K; Zong Y; Shen X; Xie Q; Liu C
J Clin Transl Hepatol; 2024 May; 12(5):505-515. PubMed ID: 38779515
[TBL] [Abstract][Full Text] [Related]
6. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet () and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial.
Li ZX; Zhao ZM; Liu P; Zheng QS; Liu CH
Chin J Integr Med; 2021 Jul; 27(7):509-513. PubMed ID: 32572776
[TBL] [Abstract][Full Text] [Related]
7. The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway.
Fu Y; Xiao Z; Tian X; Liu W; Xu Z; Yang T; Hu Y; Zhou X; Fang J; Gao S; Zhang D; Mu Y; Zhang H; Hu Y; Huang C; Chen J; Liu P
Front Pharmacol; 2021; 12():671152. PubMed ID: 34630075
[TBL] [Abstract][Full Text] [Related]
8. Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis.
Gui HL; Zhao CQ; Wang Y; Gu HT; Wang WJ; Cai W; Guo Q; Bao SS; Xu LM; Xie Q
J Clin Transl Hepatol; 2020 Sep; 8(3):277-284. PubMed ID: 33083250
[No Abstract] [Full Text] [Related]
9. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
Liu P; Hu YY; Liu C; Xu LM; Liu CH; Sun KW; Hu DC; Yin YK; Zhou XQ; Wan MB; Cai X; Zhang ZQ; Ye J; Tang BZ; He J
Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):89-98, 102. PubMed ID: 15339577
[TBL] [Abstract][Full Text] [Related]
10. Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice.
Jiang C; Iwaisako K; Cong M; Diggle K; Hassanein T; Brenner DA; Kisseleva T
Arch Clin Biomed Res; 2020; 4(5):561-580. PubMed ID: 33210080
[TBL] [Abstract][Full Text] [Related]
11. Effect of Fuzheng Huayu formula and its actions against liver fibrosis.
Liu C; Hu Y; Xu L; Liu C; Liu P
Chin Med; 2009 Jun; 4():12. PubMed ID: 19558726
[TBL] [Abstract][Full Text] [Related]
12. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
13. Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes.
Xing L; Zeng R; Huang K; Xue J; Liu H; Zhao Z; Peng Y; Hu X; Liu C
Front Pharmacol; 2022; 13():907921. PubMed ID: 36249820
[No Abstract] [Full Text] [Related]
14. Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis.
Sun X; Tan Y; Lyu J; Liu HL; Zhao ZM; Liu CH
Chin J Integr Med; 2022 Jun; 28(6):538-544. PubMed ID: 34581939
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components.
Yang T; Shen DP; Wang QL; Tao YY; Liu CH
J Ethnopharmacol; 2013 Jul; 148(2):691-700. PubMed ID: 23707207
[TBL] [Abstract][Full Text] [Related]
16. Chinese herbal formula Fuzheng Huayu alleviates CCl
Dong S; Cai FF; Chen QL; Song YN; Sun Y; Wei B; Li XY; Hu YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):930-941. PubMed ID: 29094729
[TBL] [Abstract][Full Text] [Related]
17. Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice.
Jia YH; Wang RQ; Mi HM; Kong LB; Ren WG; Li WC; Zhao SX; Zhang YG; Wu WJ; Nan YM; Yu J
Lipids Health Dis; 2012 Mar; 11():45. PubMed ID: 22452814
[TBL] [Abstract][Full Text] [Related]
18. Fuzheng Huayu Recipe Prevented and Treated CCl4-Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1.
Zhang M; Liu HL; Huang K; Peng Y; Tao YY; Zhao CQ; Hu XD; Liu CH
Evid Based Complement Alternat Med; 2020; 2020():8591892. PubMed ID: 33293994
[TBL] [Abstract][Full Text] [Related]
19. Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis.
Chen QL; Lu YY; Peng JH; Dong S; Wei B; Song YN; Zhou QM; Zhang H; Liu P; Su SB
Evid Based Complement Alternat Med; 2015; 2015():238495. PubMed ID: 26221171
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats.
Xie H; Tao Y; Lv J; Liu P; Liu C
Evid Based Complement Alternat Med; 2013; 2013():972863. PubMed ID: 23431353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
